Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.
about
Systemic delivery of oncolytic viruses: hopes and hurdlesImmune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Potentiating cancer immunotherapy using an oncolytic virusOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeStem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open QuestionsEvolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathologyAn efficient targeted drug delivery through apotransferrin loaded nanoparticlesDemonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.Converting tumor-specific markers into reporters of oncolytic virus infection.Viral oncolysis - can insights from measles be transferred to canine distemper virus?Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesPhase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.Targeted cell fusion facilitates stable heterokaryon generation in vitro and in vivo.The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.Gene therapy progress and prospects cancer: oncolytic viruses.Directing systemic oncolytic viral delivery to tumors via carrier cellsAttenuated oncolytic measles virus strains as cancer therapeuticsExpression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumorsOncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Viruses as anticancer drugs.Enhancing cytokine-induced killer cell therapy of multiple myeloma.Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.Potential of tumour cells for delivering oncolytic viruses.Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.Advances in experimental and translational research in the treatment of hepatocellular carcinomaOncolytic measles virus strains as novel anticancer agents.Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors.Engineered measles virus as a novel oncolytic therapy against prostate cancer.Measles virus for cancer therapy.Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.
P2860
Q21284969-A94D384D-3794-4F17-9EDE-62216629C5CEQ24596171-3B110087-BC4E-4310-93BE-5ACA0BBD6CFFQ24628810-7BE00147-CA73-45F6-AC85-5FC671105516Q26769977-004C3125-6B19-40A7-BA5F-88F5973EA129Q26775038-9300EFDF-E428-4FE6-AC11-B0C884D6F076Q28287124-AACB233C-28C8-42CB-9CD7-A60E9C2DB193Q28476276-A5D38074-254E-4D5D-886A-7A9C7C774ECBQ30496489-8EA2F11F-10EA-419C-AB60-639E951FC11FQ33585559-6BEE74E9-71D1-44CE-969D-C76BCA026F82Q33605148-D2748319-ECC0-4C97-A2D0-5DDFDCE77873Q33713865-65CF80E7-3034-4C3E-91E1-272BFFF21FF8Q33820717-7925AE1B-5A0C-4D7D-B5AA-1AD7A08B3633Q33906116-043705B1-FCBE-41DF-AC23-5A6529C5C726Q33924550-7A16069A-A41B-4399-B0E9-FC4DF9F8FD03Q33932032-E1F1914B-9B39-4DFA-9D8B-BBCE842BB864Q34062386-D9346F7A-3A90-43F4-AFAE-3CB94B4D2F36Q34316241-2251EC86-3ADB-459C-93BF-DD844AF1B852Q34512446-1DF1A317-0BBB-4D63-8EF8-B745B7176BD6Q34770611-A20890C6-0821-460E-BDBA-74A58EBA0C8FQ35029126-F932C0AA-A53A-408D-9179-56742BC72CD7Q35818876-AF3A7571-51AE-4C27-ADB1-EC46CD11B0C6Q36014057-8D195308-6EAB-4EB7-839A-B424252FDE99Q36099082-4B8A635B-77C1-42E6-9D8C-4F7B20BD9CCAQ36250723-EB152236-4615-4E99-8E01-EEC3AB9073C7Q36634430-0D59928A-7276-48DF-A27A-0AEBE1ADC1D7Q36850878-F69F74AB-E6DA-4E68-A14B-61B3B7F1FC02Q36892290-22A65CBA-8884-4EEE-80BB-BF87D57A095FQ37029367-61E4CD76-6633-4253-A3AD-944ED4C94BEFQ37115384-BBD9D48C-0F0B-4D5D-9CCF-02EEE2EF5EBEQ37115398-BB839EE1-2491-444E-91E8-CB89347411BDQ37120166-922698C0-6F79-4CBC-8E1E-B39D8A0EDC8AQ37122717-D13EDEF8-8CF2-4CE8-B80F-FD9B01A554BDQ37261017-D79ACFBB-ABA2-4A9B-93F2-FDB8EAB6E01CQ37280354-06CF37DF-D6C1-4D16-B8A2-ABFF44DA8C08Q37316842-7A57ECC2-906E-4EB9-8B44-F98B070E9DFCQ37332702-1A33F102-A4F3-49B8-8CC7-3B70185CBDBFQ37388577-6843CE5E-7603-4EAA-9FFB-6AE0A22FA103Q37424081-43B6FABD-ECE6-4D0C-AD96-056FF0F3576AQ37455627-2AB62F4D-15F5-464E-8799-CCDB2CE9704EQ37582184-6DE6DB54-99D4-4195-BE38-77987FC984F6
P2860
Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Infected cell carriers: a new ...... viruses in cancer virotherapy.
@en
type
label
Infected cell carriers: a new ...... viruses in cancer virotherapy.
@en
prefLabel
Infected cell carriers: a new ...... viruses in cancer virotherapy.
@en
P2093
P356
P1433
P1476
Infected cell carriers: a new ...... viruses in cancer virotherapy
@en
P2093
Boris Blechacz
Chunsheng Liu
Ianko D Iankov
James E Tarara
Jeffrey D Schmeckpeper
Mark J Federspiel
P304
P356
10.1038/SJ.MT.6300020
P577
2007-01-01T00:00:00Z